BioMarin Pharmaceutical, Inc. (BMRN)
55.95
-0.68
(-1.20%)
USD |
NASDAQ |
Oct 23, 16:00
55.96
+0.01
(+0.02%)
After-Hours: 20:00
BioMarin Pharmaceutical Market Cap : 10.83B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 10.83B |
| October 22, 2026 | 10.96B |
| October 21, 2026 | 10.69B |
| October 20, 2026 | 10.92B |
| October 19, 2026 | 10.58B |
| October 16, 2026 | 10.58B |
| October 15, 2026 | 10.85B |
| October 14, 2026 | 10.67B |
| October 13, 2026 | 10.52B |
| October 12, 2026 | 10.72B |
| October 09, 2026 | 10.60B |
| October 08, 2026 | 10.62B |
| October 07, 2026 | 10.68B |
| October 06, 2026 | 10.88B |
| October 05, 2026 | 11.14B |
| October 02, 2026 | 11.07B |
| October 01, 2026 | 11.31B |
| September 30, 2026 | 11.61B |
| September 29, 2026 | 11.59B |
| September 28, 2026 | 11.51B |
| September 25, 2026 | 11.66B |
| September 24, 2026 | 11.87B |
| September 23, 2026 | 12.04B |
| September 22, 2026 | 12.26B |
| September 21, 2026 | 12.40B |
| Date | Value |
|---|---|
| September 18, 2026 | 12.37B |
| September 17, 2026 | 12.60B |
| September 16, 2026 | 12.53B |
| September 15, 2026 | 12.47B |
| September 14, 2026 | 12.85B |
| September 11, 2026 | 12.71B |
| September 10, 2026 | 12.68B |
| September 09, 2026 | 12.47B |
| September 08, 2026 | 12.51B |
| September 04, 2026 | 12.88B |
| September 03, 2026 | 12.86B |
| September 02, 2026 | 12.96B |
| September 01, 2026 | 12.55B |
| August 31, 2026 | 12.62B |
| August 28, 2026 | 12.51B |
| August 27, 2026 | 12.64B |
| August 26, 2026 | 12.70B |
| August 25, 2026 | 12.80B |
| August 24, 2026 | 12.59B |
| August 21, 2026 | 12.91B |
| August 20, 2026 | 13.10B |
| August 19, 2026 | 13.42B |
| August 18, 2026 | 12.96B |
| August 17, 2026 | 12.90B |
| August 14, 2026 | 13.04B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 15.98B |
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Cytokinetics, Inc. | 8.496B |
Market Cap Related Metrics
| PE Ratio | 150.85 |
| PS Ratio | 3.142 |
| Price to Book Value | 1.713 |
| Price to Free Cash Flow | 14.98 |
| Price | 55.95 |
| Earnings Yield | 0.66% |
| Operating PE Ratio | 16.98 |
| Normalized PE Ratio | 28.40 |